Franklyn G Prendergast Immunome Inc. (IMNM) insider trading activity

Franklyn G Prendergast is Director of Immunome Inc.. Currently has a direct ownership of 60,840 shares of IMNM, which is worth approximately $877,921. The most recent transaction as insider was on Oct 02, 2023, when has been sold 60,840 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60.8K

0% 3M change

n/a 12M change

Total Value Held $877,921

FRANKLYN G PRENDERGAST Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 02 2023	BUY Grant, award, or other acquisition	-	60,840 Added 50.0%	60,840 Common Stock

Also insider at

VYNT

Vyant Bio, Inc. Healthcare

Director

LLY

ELI LILLY & Co Healthcare

Director

NBSE

NeuBase Therapeutics, Inc. Healthcare

Director

LTRN

Lantern Pharma Inc. Healthcare

Director

FGP